Close

Barclays on U.S. Life Science Tools: Q3 Preview: Is Sentiment Near a Bottom? Oct 17, 2011 02:55PM
Barclays Maintains an 'Overweight' on Waters Corp. (WAT); Negative Reaction Overdone; Q2 a Hiccup, Trends Not Changing Jul 27, 2011 02:32PM
Barclays Maintains an 'Overweight' on Illumina (ILMN); Moderating Expectations Due to Funding Uncertainty and New Product Dynamics Jul 27, 2011 01:05PM
Barclays on U.S. Life Science Tools: Q2 Preview; Favorites are A, ILMN, WAT Jul 19, 2011 02:03PM
Barclays Maintains an 'Overweight' on Waters Corp. (WAT); This 'Cycle' Is Far From Done Jun 3, 2011 01:17PM


May 26, 2011 03:46PM Barclays Maintains an 'Overweight' on Waters Corp. (WAT); H-class Within the Broader Acquity Strategy
May 2, 2011 03:19PM Barclays Maintains an 'Overweight' on Agilent (A); LSG - The Next Leg Of The Agilent Story
Apr 27, 2011 01:50PM Barclays Reiterates an 'Overweight' on Waters Corp. (WAT); 2011: The year of Exceeding Expectations
Apr 11, 2011 01:39PM Barclays on Life Science Tools: Q1 2011 Preview; Waters (WAT) And Agilent (A) Are Top Picks
Mar 16, 2011 11:26AM Waters (WAT) Sees FY11 EPS Up Low-Mid Teen Range, Sales Up High-Single Digit Rage
Mar 15, 2011 02:10PM Barclays on U.S. Life Science Tools: PITTCON 2011 Review
Jan 26, 2011 01:15PM Barclays Reiterates an 'Overweight' on Waters Corp. (WAT); Product Cycles Pick Up Steam
Sep 21, 2009 07:55AM Barclays Upgrades Waters Corp (WAT) to Overweight
Jan 27, 2009 10:41AM David Moenning's Daily State of the Markets: 1/27